Immunomodulatory Medication Use in Newly Diagnosed Youth With Systemic Lupus Erythematosus.

Among youth with newly diagnosed SLE, hydroxychloroquine use is prevalent although not universal, and prescription immunosuppressant use is notably low during the first year of care. Further research is needed to identify factors contributing to suboptimal immunomodulatory medication use during the first year of care.